Zydus secures tentative USFDA approval for Rifaximin Tablets 550 mg
The tablets, used for treating IBS-D in adults, will be manufactured at the company’s SEZ II facility in Ahmedabad
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.